LUNGevity Foundation shared on LinkedIn:
“LUNGevity is presenting important research at the ASCO Quality Care Symposium, held October 16-17, 2026 in Boston.
Each year this conference brings together support staff, clinicians, advocates and researchers with a shared mission of ensuring that all patients with cancer receive high-quality and empathetic care.
This year’s meeting features research presentations by LUNGevity staff that are highlighting the patient perspective and shaping important conversations about cancer care.
These research highlights include
- End-of-life planning needs
- Improving access to clinical trials
- Using AI in the clinic
- Patient perspectives on survivability
See you in Boston for the ASCO Quality Care Symposium
1․ Surviving Longer, Planning Later? Unmet Needs of End-of-Life Planning Among Long-Term Survivors With Advanced NSCLC – Kirsten Glynn, MPH (Research Manager, LUNGevity Foundation)
Abstract 295 – Poster Session A
Time: Oct. 16, 12:25 – 1:45 PM ET
2․ Will AI Widen the Gap? Exploring Lung Cancer Patient Perceptions of AI – Chelsea Ducille, PhD, MSPH (Data Analytics Research Fellow, LUNGevity Foundation)
Abstract 400 – Poster Session B
Time: Oct. 17, 7:20 – 8:20 AM ET
3․ Analysis of Biomarker Testing Requirements for Lung Cancer Clinical Trial Enrollment – Tod Guidry, PhD (Associate Director of Regulatory and Diagnostics Policy, LUNGevity Foundation)
Abstract 126 – Poster Session B
Time: Oct. 17, 7:20 – 8:20 AM ET
4․ Hope for a Cure: Exploratory Analysis of Prognostic Awareness of People Living With Advanced Lung Cancer – Chelsea Ducille, PhD, MSPH (Data Analytics Research Fellow, LUNGevity Foundation)
Abstract 402 – Poster Session B
Time: Oct. 17, 7:20 – 8:20 AM ET․”
Other articles from LUNGevity Foundation on OncoDaily.